Triple negative breast cancer (TNBC) stands out for a remarkable morphological and biological heterogeneity associated with a high propensity for systemic metastases and poor survival in comparison with the different subtype of breast cancer. The efforts to adopt specific target therapies are complicated by the difficulty to identify representative and reproducible markers. Recently, there is increasing evidence of the role of tumorinfiltrating lymphocytes (TILs) in this subtype of breast cancer in terms ofimproving disease-free (DFS) and overall survival (OS) rates.
Tumor infiltrating lymphocyte (TIL) and CD8+ cells in TNBC: new prognostic markers
QUERZOLI, Patrizia;MAGRI, Eros;
2016
Abstract
Triple negative breast cancer (TNBC) stands out for a remarkable morphological and biological heterogeneity associated with a high propensity for systemic metastases and poor survival in comparison with the different subtype of breast cancer. The efforts to adopt specific target therapies are complicated by the difficulty to identify representative and reproducible markers. Recently, there is increasing evidence of the role of tumorinfiltrating lymphocytes (TILs) in this subtype of breast cancer in terms ofimproving disease-free (DFS) and overall survival (OS) rates.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
